Emerging significance of OGT in both of these chronic diseases, that is, diabetes and cancer necessitates modeling the dynamics of the PI3K/Akt pathway in a holistic manner for a better understanding of OGT function in an insulin resistant as well as in hyperglycemic cellular state during diabetes and breast cancer. The gene discussed is AKT1; the disease is breast cancer.